Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alteplase for COVID-19 ARDS
NCT04357730Phase 2Completed
- Sponsor
- Denver Health
- Start
- May 2020
- Primary completion
- Mar 2021
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of tissue-plasminogen activator in coronavirus disease 2019 (COVID-19), acute respiratory distress syndrome (ARDS), sponsored by Denver Health. Started May 2020; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
coronavirus disease 2019 (COVID-19)acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT04357730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04357730.